Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 21.80
-0.50 (-2.24%)
At close: Feb 20, 2026
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €1.06 billion as of February 20, 2026. Its market cap has increased by 454.83% in one year.
Market Cap
1.06B
Enterprise Value
1.08B
Revenue
10.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€21.80
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 1.06B, an increase of 1,496.55%. That is a compound annual growth rate of 23.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.06B | 11.91% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.75B |
| DBV Technologies | 1.08B |
| Inventiva | 1.07B |
| Valneva SE | 825.33M |
| MedinCell | 790.50M |
| Genfit | 392.39M |
| Cellectis | 248.80M |
| Transgene | 225.09M |